1. Generics Bulletin
  2. >>Products

‘Critical To Bring Back Domestic Manufacturing Of Key Essentials’ Insists Phlow CEO

Eric Edwards Bets On Continuous Manufacturing For Sustainable Supply Chain

 
• By Akriti Seth

In an exclusive interview with Generics Bulletin, Phlow Corp CEO Eric Edwards has criticized the growing list of drug shortages in the US. He outlined the government-backed company’s objective of tackling drug shortages and supply chain vulnerabilities, to create a national stockpile of essential medicines.

Eric Edwards
Phlow CEO Eric Edwards throws light on the need for more domestic manufacturing of essential medicines • Source: Phlow Corp

“We need domestic manufacturing for key essential medicines in case of supply chain disruptions in the future,” Phlow CEO Eric Edwards has insisted, as he threw light on challenges faced by the US due to the COVID-19 pandemic in an exclusive interview with Generics Bulletin.

Phlow made headlines in May 2020 when the US government awarded federal government funding of $354m as part of a...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Generics

More from Products

Arizonans To Be Offered Up To 80% Discount On Generic Drugs

 
• By Urtė Fultinavičiūtė

Arizona’s governor Katie Hobbs pointed to Trump’s One Big Beautiful Bill and other federal failures as she signed an executive order to increase access to medications in her state.

Iron Sucrose Competition Expands With Viatris and Amphastar FDA Approvals

 
• By Dean Rudge

Viatris and Amphastar are expanding their complex generic portfolios with the planned launches of FDA-approved versions of Vifor Pharma/Daiichi Sankyo’s Venofer (iron sucrose). The FDA’s database also show Sandoz holds an approval for generic Venofer, though it has not disclosed launch plans.

Generic Drugs And AI: Maximum Daily Dose Tool Could Help US FDA Be ‘At The Forefront’

 
• By Michael McCaughan

The FDA is testing a new artificial intelligence tool to help generic drug developers automate maximum daily dose calculations.